Portfolio Companies 2026 for Seroba Life Sciences: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Seroba Life Sciences accounts for 6 tracked companies with verified cap-table data, 6 of which disclose round sizes totalling $292M. The median disclosed raise is $54M, and the largest is Medlumics at $73M, ahead of Atlantic Therapeutics ($60M) and Perfuze ($54M).
The names that recur most often on these portfolio cap tables are Seroba Life Sciences (6 companies), Andera Partners (3 companies), Kurma Partners (3 companies), LSP (3 companies), Atlantic Bridge Ventures (2 companies), Earlybird (2 companies). By latest disclosed round, the market skews Series B (3), Series E (1), Series C (1), Series A (1).